CADL Candel Therapeutics, Inc.
Nasdaq · SEC CIK 1841387 · EDGAR
- Bought, last 12 months
- $3.00M 1 purchases by 1 insiders
- Sold, last 12 months
- $3.55M 4 sales by 3 insiders
- Filings on record
- 169 since 2021-07-29, latest 2026-09-11 18:12
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Tak Paul Peter | CEO, Dir | — | $3.16M |
| Manning Paul B | Dir | $3.00M | — |
| Barone Francesca | CSO | — | $235.8K |
| Tyagarajan Seshu | CTO | — | $154.2K |
Transactions 110
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-02 | 2021-07-29 | CADL | Canepa John J | CFO | P - Purchase | $8.00 | +10.1K | 10.1K | New | +$81.0K | |
| DMI | 2021-08-02 | 2021-07-29 | CADL | Manning Paul B | Dir | C - Cnv Deriv | — | +1.23M | 553.8K | New | — |
| 2021-08-02 | 2021-07-29 | CADL | Tak Paul Peter | CEO, Dir | P - Purchase | $8.00 | +25.0K | 25.0K | New | +$200.0K | |
| 2021-08-02 | 2021-07-29 | CADL | Nguyen Diem | Dir | P - Purchase | $8.00 | +10.0K | 10.0K | New | +$80.0K | |
| D | 2021-08-02 | 2021-07-29 | CADL | Aguilar-Cordova Estuardo | CSO, Dir | C - Cnv Deriv | — | +162.1K | 1.02M | +19% | — |
| DI | 2021-08-02 | 2021-07-29 | CADL | Martell Christopher | Dir | C - Cnv Deriv | — | +283.5K | 283.5K | New | — |
| DI | 2021-08-02 | 2021-07-29 | CADL | Martell Christopher | Dir | P - Purchase | $8.00 | +125.0K | 125.0K | New | +$1.00M |
| 2021-08-02 | 2021-07-29 | CADL | Caffo Nathan | Chief Business Off | P - Purchase | $8.00 | +6,000 | 6,000 | New | +$48.0K | |
| D | 2021-08-02 | 2021-07-29 | CADL | Aguilar Laura K. | Chief Medical Off | C - Cnv Deriv | — | +56.1K | 931.0K | +6% | — |
| M | 2021-07-29 | 2021-07-27+ | CADL | Manning Paul B | Dir | P - Purchase | $7.34 | +56.0K | 56.0K | New | +$411.0K |
Purchase Sale Sale after option exercise All abbreviations